Table 3. Pathological stages of esophageal NEC patients.
Pathologic Characteristics | Total | Classification | |||||
---|---|---|---|---|---|---|---|
SCNC | LCNC | p | Mixed NEC | Pure NEC | P | ||
Differentiation (G) | |||||||
Well (G1) | 0 | 0 | 0 | 0.57 | 0 | 0 | 0.04* |
Moderate (G2) | 19 | 19 | 0 | 2 | 17 | ||
Poor (G3) | 48 | 44 | 4 | 18 | 30 | ||
Invasion | |||||||
T1 | 3 | 3 | 0 | 0.50 | 2 | 1 | 0.26 |
T2 | 14 | 13 | 1 | 3 | 11 | ||
T3 | 30 | 27 | 3 | 7 | 23 | ||
T4 | 20 | 20 | 0 | 8 | 12 | ||
Lymph node metastasis | |||||||
N0 | 43 | 40 | 3 | 0.57 | 17 | 26 | 0.07 |
N1 | 14 | 14 | 0 | 1 | 13 | ||
N2 | 7 | 6 | 1 | 1 | 6 | ||
N3 | 3 | 3 | 0 | 1 | 2 | ||
Distal Metastasis | |||||||
M0 | 58 | 54 | 4 | 1 | 15 | 43 | 0.11 |
M1 | 9 | 9 | 0 | 5 | 4 | ||
Clinical Stage | |||||||
I | 17 | 17 | 0 | 0.22 | 8 | 9 | 0.02* |
II | 18 | 17 | 1 | 3 | 15 | ||
III | 21 | 18 | 3 | 3 | 18 | ||
IV | 11 | 11 | 0 | 6 | 5 |